Market Exclusivities and Accelerating Biosimilar Entry

Panel

Panel 2: IP, Trade and Access

Moderator

Henry Liao, Partner, Schinders Law

Speaker Bio

Hans Sauer is deputy general counsel and Vice President for Intellectual Property for the Biotechnology Innovation Organization (BIO), a major trade association representing more than 1,000 biotechnology companies from the medical, agricultural, environmental, and industrial sectors. At BIO, he advises the organization's board of directors, amicus committee, and various staff committees on patent and other intellectual-property-related matters. Before taking his current position at BIO in 2006, he was chief patent counsel for MGI Pharma Inc. in Bloomington, MN, and senior patent counsel for Guilford Pharmaceuticals Inc. in Baltimore, MD. Mr. Sauer holds a M.S. degree in biology from the University of Ulm in his native Germany, a Ph.D. in neuroscience from the University of Lund, Sweden, and a J.D. degree from Georgetown University Law Center, where he serves as adjunct professor.

Location

Pacific McGeorge School of Law, Lecture Hall, 3200 Fifth Ave., Sacramento, CA

This document is currently not available here.

Share

COinS
 
Apr 5th, 9:25 AM Apr 5th, 10:25 AM

Market Exclusivities and Accelerating Biosimilar Entry

Pacific McGeorge School of Law, Lecture Hall, 3200 Fifth Ave., Sacramento, CA